共 50 条
[7]
New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
[J].
THERAPEUTICS AND CLINICAL RISK MANAGEMENT,
2016, 12
:225-232
[10]
Safety of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Nephrotoxicity Rates Compared with Vancomycin: A Post Hoc Analysis of Three Clinical Trials
[J].
Infectious Diseases and Therapy,
2021, 10
:471-481